RTSN Award Disclosure
Keller Eric L. · SEC Form 4 · Filed Oct 22, 2026
Award
Calculated transaction value
$0
Keller Eric L. Chief Executive Officer
RTSN
Transaction date
Oct 22, 2026
Public filing date
Oct 22, 2026
Filing lag
Filed same day
RTSN daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 40,884 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-111795
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Retension Pharmaceuticals, Inc. RTSN Current | Award | Oct 22, 2026 | $0 |